Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in non-diabetic metabolic syndrome patients for cardiovascular and psychiatric status
IRCT201101023733N2Phase 4Completed
- Sponsor
- Osveh Pharmaceutical
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pioglitazone in cardiometabolic risk (CMR), sponsored by Osveh Pharmaceutical. Started Mar 2011; status: completed.
02
Drugs
pioglitazone
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT201101023733N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201101023733N2.